You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNTO 328

Showing 1 - 25 of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

Recruiting
  • Non-Hodgkin Lymphoma
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 13, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Multiple Myeloma Trial in Worldwide (Siltuximab, Bortezomib, Placebo)

Completed
Has Results
  • Multiple Myeloma
  • Siltuximab
  • +3 more
  • Greenbrae, California
  • +83 more
Nov 7, 2019

Metastatic Colorectal Cancer Trial in Hangzhou (FOLFIRI)

Recruiting
  • Metastatic Colorectal Cancer
  • Hangzhou, Zhejinag, China
    SAHZU
Apr 30, 2022

Multicentric Castleman's Disease Trial in Worldwide (Siltuximab, Placebo, Best Supportive Care (BSC))

Completed
Has Results
  • Multicentric Castleman's Disease
  • Little Rock, Arkansas
  • +56 more
Feb 22, 2018

Chronic Tension-Type Headache Trial (Suboccipital Myofascial Release(MFR) with sham Deep Neck Flexor(DNF)exercise, Deep Neck

Not yet recruiting
  • Chronic Tension-Type Headache
  • Suboccipital Myofascial Release(MFR) with sham Deep Neck Flexor(DNF)exercise
  • Deep Neck Flexor(DNF)exercise with sham Suboccipital Myofascial Release(MFR)
  • (no location specified)
Aug 2, 2022

Non Small Cell Lung Cancer Trial (Jinfukang oral liquid, Platinum-based doublet chemo)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Jinfukang oral liquid
  • Platinum-based doublet chemotherapy
  • (no location specified)
Oct 17, 2021

Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo for guselkumab, Adalimumab)

Completed
Has Results
  • Psoriasis
  • Guselkumab 100 mg
  • +3 more
  • Los Angeles, California
  • +97 more
Jul 22, 2021

Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo for guselkumab, Adalimumab)

Completed
Has Results
  • Psoriasis
  • Guselkumab 100 mg
  • +3 more
  • Birmingham, Alabama
  • +95 more
Jun 29, 2021

HIV Trial in Iowa City, New York (Tetanus Toxoid Vaccine, Hepatitis A Vaccine (Inactivated), HIV-1 Immunogen)

Completed
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +3 more
  • Iowa City, Iowa
  • +1 more
Oct 27, 2021

Respiratory Tract Diseases Trial (intratracheal administration of surfactant/budesonide, incidence of bronchopulmonary

Not yet recruiting
  • Respiratory Tract Diseases
  • intratracheal administration of surfactant/budesonide
  • incidence of bronchopulmonary dysplasia
  • (no location specified)
Sep 9, 2022

Aphthous Stomatitis Trial in Sant Cugat del Vallès (GV-328)

Completed
  • Aphthous Stomatitis
  • Sant Cugat del Vallès, Barcelona, Spain
    Universitat Internacional de Catalunya
Jan 29, 2021

Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Entecavir
  • Entecavir combined with Tenofovir Amibufenamide
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
May 15, 2022

Psoriasis Trial in Japan (CNTO 1959 50 mg, CTNO 1959 100 mg, Placebo 50 mg)

Completed
Has Results
  • Psoriasis
  • CNTO 1959 50 mg
  • +3 more
  • Asahikawa, Japan
  • +26 more
May 20, 2020

China Nutrition Fundamental Data 2020

Completed
  • Nutritional Status of Chinese Inpatients；Nutritional Service Capacity of Medical Institutions in China
  • Malnutrition
  • Beijing, Beijing, China
    Dongcheng district，Peking union medical college hospital
Jan 20, 2023

Asthma, Atopic Dermatitis, Healthy Trial in Belgium, Germany (Part 1: CNTO 7160, Part 2 (Asthma): CNTO 7160, Part 2 (Atopic

Completed
  • Asthma
  • +2 more
  • Part 1: CNTO 7160
  • +3 more
  • Antwerp, Belgium
  • +6 more
Nov 12, 2020

Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

Completed
Has Results
  • Arthritis, Psoriatic
  • Birmingham, Alabama
  • +137 more
Dec 20, 2022

Pustular Psoriasis Trial in Japan (Guselkumab)

Completed
  • Pustular Psoriasis
  • Asahikawa, Japan
  • +19 more
Oct 22, 2019

High-risk Smoldering Multiple Myeloma Trial in Worldwide (Siltuximab, Placebo)

Completed
Has Results
  • High-risk Smoldering Multiple Myeloma
  • Chicago, Illinois
  • +39 more
Jan 23, 2020

Visual Acuity, Geographic Atrophy, Macular Degeneration Trial in United States (CNTO 2476 3.0 x 10^5 cells, Subretinal Delivery

Completed
Has Results
  • Visual Acuity
  • +2 more
  • CNTO 2476 3.0 x 10^5 cells
  • Subretinal Delivery System
  • Arcadia, California
  • +7 more
Jun 2, 2020

Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis Trial (procedure, other, biological)

Withdrawn
  • Myelofibrosis
  • +3 more
  • Bone Marrow Aspiration and Biopsy
  • +2 more
  • (no location specified)
Oct 21, 2016

Arthritis, Rheumatoid Trial in Worldwide (Sirukumab 100 mg, Sirukumab 50 mg, Placebo)

Completed
Has Results
  • Arthritis, Rheumatoid
  • Sirukumab 100 mg
  • +2 more
  • Birmingham, Alabama
  • +200 more
Apr 12, 2019

Advanced Urothelial Cancer, Metastatic Urothelial Cancer Trial in France (Carboplatin, Fractionated Cisplatin, Gemcitabine)

Completed
  • Advanced Urothelial Cancer
  • Metastatic Urothelial Cancer
  • Angers, France
  • +17 more
Aug 7, 2019

Psoriatic Arthritis Trial in Worldwide (Guselkumab, Ustekinumab, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • Huntsville, Alabama
  • +40 more
Sep 21, 2020

Psoriasis Trial in Worldwide (Guselkumab, Placebo, Secukinumab)

Completed
Has Results
  • Psoriasis
  • Birmingham, Alabama
  • +141 more
Sep 6, 2019